Bi, Zhao-Feng
10731  results:
Search for persons X
?
1

Head-to-head immunogenicity comparison of an Escherichia co..:

Zhu, Feng-Cai ; Zhong, Guo-Hua ; Huang, Wei-Jin...
The Lancet Infectious Diseases.  23 (2023)  11 - p. 1313-1322 , 2023
 
?
3

Safety and immunogenicity of an Escherichia coli-produced 9..:

Chu, Kai ; Bi, Zhao-Feng ; Huang, Wei-Jin...
The Lancet Regional Health - Western Pacific.  34 (2023)  - p. 100731 , 2023
 
?
4

Safety and immunogenicity of an Escherichia coli-produced b..:

Mo, Zhao-Jun ; Bi, Zhao-Feng ; Sheng, Wei...
Human Vaccines & Immunotherapeutics.  18 (2022)  6 - p. , 2022
 
?
5

Inflammation-related adverse reactions following vaccinatio..:

Zhuang, Chun-Lan ; Lin, Zhi-Jie ; Bi, Zhao-Feng...
Emerging Microbes & Infections.  10 (2021)  1 - p. 365-375 , 2021
 
?
6

Safety and immunogenicity of an Escherichia coli-produced 9..:

Chu, Kai ; Bi, Zhao-Feng ; Huang, Wei-Jin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240382/.  , 2023
 
?
 
?
10

Clinical features, microbial spectrum, and antibiotic susce..:

Zhang, Xin ; Li, Xiao-Xi ; Song, Jin-Wen...
Digestive and Liver Disease.  55 (2023)  11 - p. 1554-1561 , 2023
 
?
11

Cause of death and influencing factors of chronic renal fai..:

Fan, Xing ; Li, Jing ; Bi, Zhao-yu..
Pakistan Journal of Medical Sciences.  39 (2023)  5 - p. , 2023
 
?
13

Exploring an Integrative Therapy for Treating COVID-19: A R..:

Wang, Jia-bo ; Wang, Zhong-xia ; Jing, Jing...
Chinese Journal of Integrative Medicine.  26 (2020)  9 - p. 648-655 , 2020
 
?
14

Population Pharmacokinetics of Voriconazole and Optimizatio..:

Ren, Qiu-xia ; Li, Xin-gang ; Mu, Jin-song...
Journal of Pharmaceutical Sciences.  108 (2019)  12 - p. 3923-3931 , 2019
 
1-15